v3.25.2
Accrued and Other Liabilities
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Payables and Accruals [Abstract]    
Accrued and Other Liabilities

7. Accrued and Other Liabilities

 

Accrued and other current liabilities consisted of the following (in $000s):

 

   March 31,   December 31, 
   2025   2024 
Accrued research and development  $   $1,300 
Accrued legal and professional fees   532    87 
Other current liabilities   17    284 
Accrued and other current liabilities  $549   $1,671 

 

9. Accrued and Other Current Liabilities

 

Accrued and other current liabilities consisted of the following at December 31, 2024 and 2023 (in thousands):

 

   December 31,   December 31, 
   2024   2023 
Accrued research and development  $1,299   $3,668 
Accrued legal and professional fees   87    570 
Other current liabilities   283    380 
 Accrued and other current liabilities  $1,669   $4,618 

 

As at December 31, 2024, the Company had accounts payables of $4.6 million, of which $4.1 million related to the UK subsidiary. As at December 31, 2023, the Company had accounts payables of $3.5 million, of which $3.1 million related to the UK subsidiary.